Related references
Note: Only part of the references are listed.New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
Werner Brannath et al.
STATISTICS IN MEDICINE (2009)
Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint
Heinz Schmidli et al.
STATISTICS IN MEDICINE (2007)
Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect
Wenyu Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
Sue-Jane Wang et al.
PHARMACEUTICAL STATISTICS (2007)
Adaptive seamless designs: Selection and prospective testing of hypotheses
Christopher Jennison et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim:: General concepts
Frank Bretz et al.
BIOMETRICAL JOURNAL (2006)
Planning and analyzing adaptive group sequential survival trials
Gernot Wassmer
BIOMETRICAL JOURNAL (2006)
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: Applications and practical considerations
Heinz Schmidli et al.
BIOMETRICAL JOURNAL (2006)
A regulatory view on adaptive/flexible clinical trial design
H. M. James Hung et al.
BIOMETRICAL JOURNAL (2006)
Methodological issues with adaptation of clinical trial design
H. M. James Hung et al.
PHARMACEUTICAL STATISTICS (2006)
Operational challenges in adaptive design implementation
P Gallo
PHARMACEUTICAL STATISTICS (2006)
Testing and estimation in flexible group sequential designs with adaptive treatment selection
M Posch et al.
STATISTICS IN MEDICINE (2005)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)
Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections
H Schäfer et al.
STATISTICS IN MEDICINE (2004)
Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer
P Royston et al.
STATISTICS IN MEDICINE (2003)
Sequential designs for phase III clinical trials incorporating treatment selection
N Stallard et al.
STATISTICS IN MEDICINE (2003)
The mixture approach for simulating bivariate distributions with specified correlations
JR Michael et al.
AMERICAN STATISTICIAN (2002)